Obesity as a Disease: A Primer on Clinical and Physiological Insights
References
- Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000:894:i-xii, 1-253. PMID: 11234459
- Fitch AK, Bays HE. Obesity definition, diagnosis, bias, standard operating procedures (SOPs), and telehealth: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022. Obese Pillars. 2022 Jan 15:1:
100004 . doi: 10.1016/j.obpill.2021.100004 - Boutari C, Mantzoros CS. A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on. Metabolism. 2022 Aug:133:
155217 . doi: 10.1016/j.metabol.2022.155217 - CDC [Internet]. Atlanta, GA: Centers for Disease Control and Prevention; c2024.
BRFSS Prevalence & Trends Data: Home ; 2023 [cited 2024 Dec 15]. Available from:https://www.cdc.gov/brfss/brfssprevalence/index.html - Joynt Maddox KE, Elkind MSV, Aparicio HJ, et al. Forecasting the Burden of Cardiovascular Disease and Stroke in the United States Through 2050-Prevalence of Risk Factors and Disease: A Presidential Advisory From the American Heart Association. Circulation. 2024 Jul 23;150(4):e65-e88. doi: 10.1161/CIR.0000000000001256
- Hall KD, Hammond RA, Rahmandad H. Dynamic interplay among homeostatic, hedonic, and cognitive feedback circuits regulating body weight. Am J Public Health. 2014 Jul;104(7):1169-75. doi: 10.2105/AJPH.2014.301931
- Busebee B, Ghusn W, Cifuentes L, Acosta A. Obesity: A Review of Pathophysiology and Classification. Mayo Clin Proc. 2023 Dec;98(12):1842-1857. doi: 10.1016/j.mayocp.2023.05.026
- Kim JH, Choi JH. Pathophysiology and clinical characteristics of hypothalamic obesity in children and adolescents. Ann Pediatr Endocrinol Metab. 2013 Dec;18(4):161-7. doi: 10.6065/apem.2013.18.4.161
- Ribeiro G, Maia A, Cotovio G, Oliveira FPM, Costa DC, Oliveira-Maia AJ. Striatal dopamine D2-like receptors availability in obesity and its modulation by bariatric surgery: a systematic review and meta-analysis. Sci Rep. 2023 Mar 27;13(1):
4959 . doi: 10.1038/s41598-023-31250-2 - Wachsmuth HR, Weninger SN, Duca FA. Role of the gut-brain axis in energy and glucose metabolism. Exp Mol Med. 2022 Apr;54(4):377-392. doi: 10.1038/s12276-021-00677-w
- Bays HE. Adiposopathy is “sick fat” a cardiovascular disease? J Am Coll Cardiol. 2011 Jun 21;57(25):2461-73. doi: 10.1016/j.jacc.2011.02.038
- Izquierdo AG, Crujeiras AB, Casanueva FF, Carreira MC. Leptin, Obesity, and Leptin Resistance: Where Are We 25 Years Later? Nutrients. 2019;11(11):
2704 . doi: 10.3390/nu11112704 - Endotext [Internet]. Bethesda, MD: National Library of Medicine; c2024. Woolf EK, Cabre HE, Niclou AN, Redman LM. Body Weight Regulation; 2024 Jun 13 [cited 2024 Dec 15]. Available from:
http://www.ncbi.nlm.nih.gov/books/NBK278932/ - Garvey WT. Is Obesity or Adiposity-Based Chronic Disease Curable: The Set Point Theory, the Environment, and Second-Generation Medications. Endocr Pract. 2022 Feb;28(2):214-222. doi: 10.1016/j.eprac.2021.11.082
- Ravussin E, Bouchard C. Human genomics and obesity: finding appropriate drug targets. Eur J Pharmacol. 2000 Dec 27;410(2-3):131-145. doi: 10.1016/s0014-2999(00)00811-6
- Lake A, Townshend T. Obesogenic environments: exploring the built and food environments. J R Soc Promot Health. 2006 Nov;126(6):262-7. doi: 10.1177/1466424006070487
- Ghosh-Dastidar B, Cohen D, Hunter G, et al. Distance to store, food prices, and obesity in urban food deserts. Am J Prev Med. 2014 Nov;47(5):587-95. doi: 10.1016/j.amepre.2014.07.005
- Hall KD, Ayuketah A, Brychta R, et al. Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake. Cell Metab. 2019 Jul 2;30(1):67-77.e3. doi: 10.1016/j.cmet.2019.05.008
- Anekwe CV, Jarrell AR, Townsend MJ, Gaudier GI, Hiserodt JM, Stanford FC. Socioeconomics of Obesity. Curr Obes Rep. 2020 Sep;9(3):272-279. doi: 10.1007/s13679-020-00398-7
- Bray MS, Loos RJF, McCaffery JM, et al. NIH working group report-using genomic information to guide weight management: From universal to precision treatment. Obesity (Silver Spring). 2016 Jan;24(1):14-22. doi: 10.1002/oby.21381
- Rosen H. Is Obesity A Disease or A Behavior Abnormality? Did the AMA Get It Right? Mo Med. 2014 Mar-Apr;111(2):104-108. PMID: 30323513
- Kilpeläinen TO, Qi L, Brage S, et al. Physical activity attenuates the influence of FTO variants on obesity risk: a meta-analysis of 218,166 adults and 19,268 children. PLoS Med. 2011 Nov;8(11):
e1001116 . doi: 10.1371/journal.pmed.1001116 - King LK, March L, Anandacoomarasamy A. Obesity & osteoarthritis. Indian J Med Res. 2013;138(2):185-93. PMID: 24056594
- Vincent HK, Heywood K, Connelly J, Hurley RW. Obesity and weight loss in the treatment and prevention of osteoarthritis. PM R. 2012 May;4(5 Suppl):S59-67. doi: 10.1016/j.pmrj.2012.01.005
- Romero-Corral A, Caples SM, Lopez-Jimenez F, Somers VK. Interactions between obesity and obstructive sleep apnea: implications for treatment. Chest. 2010 Mar;137(3):711-9. doi: 10.1378/chest.09-0360
- Jin X, Qiu T, Li L, et al. Pathophysiology of obesity and its associated diseases. Acta Pharm Sin B. 2023 Jun;13(6):2403-2424. doi: 10.1016/j.apsb.2023.01.012
- Michaelidou M, Pappachan JM, Jeeyavudeen MS. Management of diabesity: Current concepts. World J Diabetes. 2023 Apr 15;14(4):396-411. doi: 10.4239/wjd.v14.i4.396
- Farag YMK, Gaballa MR. Diabesity: an overview of a rising epidemic. Nephrol Dial Transplant. 2011 Jan;26(1):28-35. doi: 10.1093/ndt/gfq576
- Marso SP, Bain SC, Consoli A, et al. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med. 2016 Nov 10;375(19):1834-1844. doi: 10.1056/NEJMoa1607141
- Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021 Mar 18;384(11):989-1002. doi: 10.1056/NEJMoa2032183
- Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med. 2023 Dec 14;389(24):2221-2232. doi: 10.1056/NEJMoa2307563
- Perkovic V, Tuttle KR, Rossing P, et al. Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes. N Engl J Med. 2024 Jul 11;391(2):109-121. doi: 10.1056/NEJMoa2403347
- Ding Y, Deng Q, Yang M, Niu H, Wang Z, Xia S. Clinical Classification of Obesity and Implications for Metabolic Dysfunction-Associated Fatty Liver Disease and Treatment. Diabetes Metab Syndr Obes. 2023 Oct 25:16:3303-3329. doi: 10.2147/DMSO.S431251
- Ordóñez-Vázquez AL, Beltrán-Gall SM, Pal SC, Méndez-Sánchez N. Editorial: Treatment with Dual Incretin Receptor Agonists to Maintain Normal Glucose Levels May Also Maintain Normal Weight and Control Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD). Med Sci Monit. 2022 Sep 12:28:
e938365 . doi: 10.12659/MSM.938365 - Masenga SK, Kabwe LS, Chakulya M, Kirabo A. Mechanisms of Oxidative Stress in Metabolic Syndrome. Int J Mol Sci. 2023 Apr 26;24(9):
7898 . doi: 10.3390/ijms24097898 - Giovannucci E. Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr. 2001 Nov;131(11 Suppl):3109S-20S. doi: 10.1093/jn/131.11.3109S
- Andò S, Gelsomino L, Panza S, et al. Obesity, Leptin and Breast Cancer: Epidemiological Evidence and Proposed Mechanisms. Cancers (Basel). 2019 Jan 9;11(1):62. doi: 10.3390/cancers11010062
- Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002 Mar 5;105(9):1135-43. doi: 10.1161/hc0902.104353
- Shu H, Cheng J, Li N, et al. Obesity and atrial fibrillation: a narrative review from arrhythmogenic mechanisms to clinical significance. Cardiovasc Diabetol. 2023 Jul 29;22(1):192. doi: 10.1186/s12933-023-01913-5
- Borlaug BA, Jensen MD, Kitzman DW, Lam CSP, Obokata M, Rider OJ. Obesity and heart failure with preserved ejection fraction: new insights and pathophysiological targets. Cardiovasc Res. 2023 Feb 3;118(18):3434-3450. doi: 10.1093/cvr/cvac120
- Jamaly S, Carlsson L, Peltonen M, Jacobson P, Karason K. Surgical obesity treatment and the risk of heart failure. Eur Heart J. 2019 Jul 1;40(26):2131-2138. doi: 10.1093/eurheartj/ehz295
- Rubino F, Puhl RM, Cummings DE, et al. Joint international consensus statement for ending stigma of obesity. Nat Med. 2020 Apr;26(4):485-497. doi: 10.1038/s41591-020-0803-x
- Puhl RM, Heuer CA. The stigma of obesity: a review and update. Obesity (Silver Spring). 2009 May;17(5):941-64. doi: 10.1038/oby.2008.636
- Sharma AM, Kushner RF. A proposed clinical staging system for obesity. Int J Obes (Lond). 2009 Mar;33(3):289-95. doi: 10.1038/ijo.2009.2
- Phelan SM, Bauer KW, Bradley D, et al. A model of weight-based stigma in health care and utilization outcomes: Evidence from the learning health systems network. Obesity Sci Pract. 2021 Aug 27;8(2):139-146. doi: 10.1002/osp4.553
- Puhl RM, Himmelstein MS, Pearl RL. Weight stigma as a psychosocial contributor to obesity. Am Psychol. 2020 Feb-Mar;75(2):274-289. doi: 10.1037/amp0000538
- Stanford FC, Lee M, Hur C. Race, Ethnicity, Sex, and Obesity: Is It Time to Personalize the Scale? Mayo Clin Proc. 2019 Feb;94(2):362-363. doi: 10.1016/j.mayocp.2018.10.014
- Garvey WT, Mechanick JI, Brett EM, et al. American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity. Endocr Pract. 2016 Jul:22 Suppl 3:1-203. doi: 10.4158/EP161365.GL
- Canning KL, Brown RE, Wharton S, Sharma AM, Kuk JL. Edmonton Obesity Staging System Prevalence and Association with Weight Loss in a Publicly Funded Referral-Based Obesity Clinic. J Obes. 2015:2015:
619734 . doi: 10.1155/2015/619734 - Kushner RF, Ryan DH. Assessment and lifestyle management of patients with obesity: clinical recommendations from systematic reviews. JAMA. 2014 Sep 3;312(9):943-52. doi: 10.1001/jama.2014.10432
- Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health. 2009 Mar 25:9:88. doi: 10.1186/1471-2458-9-88
- Taheri E, Moslem A, Mousavi-Jarrahi A, et al. Predictors of metabolic-associated fatty liver disease (MAFLD) in adults: a population-based study in Northeastern Iran. Gastroenterol Hepatol Bed Bench. 2021 Fall;14(Suppl1):S102-S111.
- Lean ME, Leslie WS, Barnes AC, et al. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet. 2018 Feb 10;391(10120):541-551. doi: 10.1016/S0140-6736(17)33102-1
- Ryan DH, Yockey SR. Weight Loss and Improvement in Comorbidity: Differences at 5%, 10%, 15%, and Over. Curr Obes Rep. 2017 Jun;6(2):187-194. doi: 10.1007/s13679-017-0262-y
- Pack QR, Rodriguez-Escudero JP, Thomas RJ, et al. The prognostic importance of weight loss in coronary artery disease: a systematic review and meta-analysis. Mayo Clin Proc. 2014 Oct;89(10):1368-77. doi: 10.1016/j.mayocp.2014.04.033
DOI: https://doi.org/10.14797/mdcvj.1515 | Journal eISSN: 1947-6108
Language: English
Page range: 4 - 13
Submitted on: Nov 1, 2024
Accepted on: Dec 11, 2024
Published on: Feb 18, 2025
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services
Keywords:
© 2025 Aayush Shah, Orhun Davarci, Peter Chaftari, Eleonora Avenatti, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.